AKT1 and ovarian carcinoma: While, in ovarian cancers LNK mainly activated the p-AKT and p-MAPK pathways, improved cell adhesion, moderated cell migration, and advanced in vivo tumor growth in a murine xenograft model [14], which is similar to TNBC.